Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.

Anu-Maaria Sandmair,Marita Turunen,Kristiina Tyynelä,Sami Loimas,Pauli Vainio,Ritva Vanninen,Matti Vapalahti,Rolf Bjerkvig,Juhani Jänne,Seppo Ylä-Herttuala

Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.

2000

Anu-Maaria Sandmair
Marita Turunen
Kristiina Tyynelä
Sami Loimas
Pauli Vainio
Ritva Vanninen
Matti Vapalahti
Rolf Bjerkvig
Juhani Jänne
Seppo Ylä-Herttuala

Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions

Keywords:

Molecular biology
Herpes Simplex Virus Thymidine Kinase Gene
Virology
Biology
Thymidine
Glioma
Thymidine kinase
Vimentin
Transfection
Microglia
In vivo
Astrogliosis
Apoptosis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations